Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In a recent study published in the Journal of Clinical Investigation , researchers reviewed the anti-inflammatory effects and mechanisms of glucagon-like peptide 1 (GLP-1)-based therapies
, -1 5 ( ), ( ) ( )
Food and Drug Administration (FDA) for all uses
Product Specifications Synonyms: LY3298176, P1206, tirzepatida, tirzepatidum CAS Number: 2023788-19-2 Molecular Formula: CHNO Molecular Weight: 4813.48 g/mol g/mol Peptide Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH Purity: 95% (verified by HPLC and mass spectrometry) Packaging Format: 40 mg lyophilized powder in a sealed research-grade vial Storage Conditions: Store 28 C (20 C long term)
UPDATE says the ingredient provides most of the effects consumers typically seek from caffeine, including alertness, focus and mental stamina, but is associated with lower rates of anxiety, racing heart rate and subsequent energy crashes compared to equivalent doses of caffeine
Most patients self-inject at home after being trained by their provider
US$ 25.61
US$ 29.61
US$ 25.10
US$ 29.13
US$ 28.13
US$ 25.46
US$ 29.89
